Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused.
Where this comes from
- Record sourced from PubMed, PMID 18021039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Australian health systems must rise to the challenge of providing thrombolysis to more stroke patients.